Evidence map›Paper›PMID 38024609›Full record

ArticleEJHaem2023

Clinical and haematological characteristics of 38 individuals with Hb G-Makassar in Malaysia.

Ezalia Esa, Ahmad Sabry Mohamad, Roszymah Hamzah, Faidatul Syazlin Abdul Hamid, Nur Aisyah Aziz, Veena Sevaratnam, Jameela Sathar, Guo Chen, Norafiza Mohd Yasin

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Characterization of New Alpha Zero (αDiagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ezalia EsaInstitute for Medical Research Setia Alam Selangor Malaysia.
Ahmad Sabry MohamadMedical Engineering Universiti Kuala Lumpur British Malaysian Institute Gombak Selangor Malaysia.
Roszymah HamzahHematology Department Ampang Hospital Ampang Selangor Malaysia.ORCID https://orcid.org/0000-0002-9371-6838
Faidatul Syazlin Abdul HamidInstitute for Medical Research Setia Alam Selangor Malaysia.
Nur Aisyah AzizInstitute for Medical Research Setia Alam Selangor Malaysia.
Veena SevaratnamHematology Department Ampang Hospital Ampang Selangor Malaysia.
Jameela SatharHematology Department Ampang Hospital Ampang Selangor Malaysia.
Guo ChenBeam Therapeutics Inc. Cambridge Massachusetts USA.
Norafiza Mohd YasinInstitute for Medical Research Setia Alam Selangor Malaysia.
Institute for Medical Research · MYKPJ Ampang Puteri Specialist Hospital · MYBeam Therapeutics (United States) · USUniversity of Kuala Lumpur · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemoglobin (Hb) G-Makassar is a rare Hb variant. It presents a diagnostic challenge as it imitates sickle Hb (Hb S) in standard electrophoresis and high-performance liquid chromatography assays requiring DNA analysis to confirm diagnosis. Both have point mutations in codon 6, exon 1 in the β-globin (

Indexed as

clinical phenotypegenotypehaematological characteristicsHb G‐Makassar

Identifiers

PMID38024609
PMCPMC10660101
OpenAlexW4385765545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.